Montana, think about the conservative nature of JT for a second...you really think he gambles the ENTIRE company again for the second time on a coin flip? No shot IMO. That would be suicidal. He would have to be held accountable if they lost again and would almost guarantee he be fired and would lose all those stock options...they derisk as soon as possible so they can have a clean BO now that they are not slow playing Europe. A deal of some sort occurs in Q3.
Guys, not sure if you have read post 281406 by blue? I used to think settlement at this point is sheer daydreaming, but seems it has precedent and the court actually ordered both sides to sit for mediation. The example showed a settlement, after oral, to reinstate patents
Do realize most of the time this TTE has been playing the roll of class clown on this board..Changing his identity monthly..And now you think he is the "Sage of Omaha."
None of us including "TTE", "The Bus", TasGreWaf (stands for "Tasty green Wafers")...Know how this trial is going to play out.
Settlement is an option..Right now the whole situation is very convoluted because the court at best has the Generics in a position where the temptation to shoe horn into the R-I indication is overwhelming..But from a legal standpoint it would be breaking the law..If they are caught (and right now nobody can put odds on that)...It could be very expensive.
In the meantime..Winning the MARINE indication..is back seat in the garbage wagon..The FDA label for Indications and Usage is the same for both The Marine Vascepa label and for Generic Lovaza..The exact word for word same..The fact V cures CVD does not come into play and if the generics try and promote this they will be indirectly inducing patent infringement..
The generics are dammed if they do..or dammed if they don't..Unless they can figure out a way to produce and sell Marine Gen Vascepa at a price lower than Teva can sell gen L then they are going to lose most of their market for Gen Vascepa..
News 
Market Data 
Discover 
